Integra Lifesciences Holdings Corp (IART)
29.12
-2.51
(-7.94%)
USD |
NASDAQ |
Apr 19, 12:25
Integra Lifesciences Holdings Price to Book Value: 1.441 for April 19, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 1.566 |
| April 17, 2024 | 1.581 |
| April 16, 2024 | 1.575 |
| April 15, 2024 | 1.587 |
| April 12, 2024 | 1.624 |
| April 11, 2024 | 1.641 |
| April 10, 2024 | 1.687 |
| April 09, 2024 | 1.713 |
| April 08, 2024 | 1.705 |
| April 05, 2024 | 1.683 |
| April 04, 2024 | 1.673 |
| April 03, 2024 | 1.678 |
| April 02, 2024 | 1.659 |
| April 01, 2024 | 1.719 |
| March 28, 2024 | 1.755 |
| March 27, 2024 | 1.724 |
| March 26, 2024 | 1.671 |
| March 25, 2024 | 1.653 |
| March 22, 2024 | 1.671 |
| March 21, 2024 | 1.704 |
| March 20, 2024 | 1.688 |
| March 19, 2024 | 1.699 |
| March 18, 2024 | 1.695 |
| March 15, 2024 | 1.718 |
| March 14, 2024 | 1.725 |
| Date | Value |
|---|---|
| March 13, 2024 | 1.771 |
| March 12, 2024 | 1.776 |
| March 11, 2024 | 1.793 |
| March 08, 2024 | 1.809 |
| March 07, 2024 | 1.778 |
| March 06, 2024 | 1.779 |
| March 05, 2024 | 1.801 |
| March 04, 2024 | 1.770 |
| March 01, 2024 | 1.773 |
| February 29, 2024 | 1.818 |
| February 28, 2024 | 1.905 |
| February 27, 2024 | 2.181 |
| February 26, 2024 | 2.173 |
| February 23, 2024 | 2.202 |
| February 22, 2024 | 2.208 |
| February 21, 2024 | 2.203 |
| February 20, 2024 | 2.225 |
| February 16, 2024 | 2.217 |
| February 15, 2024 | 2.203 |
| February 14, 2024 | 2.149 |
| February 13, 2024 | 2.102 |
| February 12, 2024 | 2.163 |
| February 09, 2024 | 2.089 |
| February 08, 2024 | 2.054 |
| February 07, 2024 | 2.027 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.442
Minimum
Apr 19 2024
4.236
Maximum
Apr 27 2021
2.993
Average
3.086
Median
May 19 2020
Price to Book Value Benchmarks
| Stryker Corp | 6.653 |
| OraSure Technologies Inc | 0.9039 |
| Insulet Corp | 15.49 |
| PROCEPT BioRobotics Corp | 9.040 |
| Perspective Therapeutics Inc | 11.40 |
Price to Book Value Related Metrics
| PE Ratio | 35.08 |
| PS Ratio | 1.517 |
| Price to Free Cash Flow | 32.00 |
| Price | 29.12 |
| Earnings Yield | 2.85% |
| Market Cap | 2.289B |
| Operating PE Ratio | 20.97 |
| Normalized PE Ratio | 35.08 |